Communication of Survival Data in US Food and Drug Administration–Approved Labeling of Cancer Drugs

This cross-sectional study examines how information on overall survival benefits of novel cancer drug indications is communicated in labeling.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Intern Med
Main Authors: Naci, Huseyin, Guan, Xiaodong, Woloshin, Steven, Xu, Ziyue, Wagner, Anita K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8276121/
https://ncbi.nlm.nih.gov/pubmed/34251420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.3505
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados